Active	Status	Sponsor type	Region	Phase	Filter
10 Active 9 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « February » « 2025 » M T W T F S S 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 1 2   - « February » « 2025 » M T W T F S S 27 28 29 30 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 1 2   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lin, Feng
NCT05395416: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C	Recruiting	2/3	520	RoW	HEC74647PA+HEC110114, Antaitavir Hasophate+Yiqibuvir, Placebo	Sunshine Lake Pharma Co., Ltd.	Chronic HCV Infection	04/23	04/23
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection	Completed	2	250	RoW	GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table	Sunshine Lake Pharma Co., Ltd.	Chronic HBV Infection	06/22	09/23
NCT05970666: Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma	Recruiting	2	71	RoW	TACE with adebrelimab and bevacizumab	The First Affiliated Hospital of Xiamen University, Jiangsu HengRui Medicine Co., Ltd.	Adebrelimab, Hepatocellular Carcinoma, Transformation, Bevacizumab, TACE	11/26	11/26
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma	Recruiting	N/A	300	RoW		Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.	Hepatocellular Carcinoma	03/26	03/26

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Lin, Feng
NCT05395416: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C	Recruiting	2/3	520	RoW	HEC74647PA+HEC110114, Antaitavir Hasophate+Yiqibuvir, Placebo	Sunshine Lake Pharma Co., Ltd.	Chronic HCV Infection	04/23	04/23
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection	Completed	2	250	RoW	GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table	Sunshine Lake Pharma Co., Ltd.	Chronic HBV Infection	06/22	09/23
NCT05970666: Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma	Recruiting	2	71	RoW	TACE with adebrelimab and bevacizumab	The First Affiliated Hospital of Xiamen University, Jiangsu HengRui Medicine Co., Ltd.	Adebrelimab, Hepatocellular Carcinoma, Transformation, Bevacizumab, TACE	11/26	11/26
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma	Recruiting	N/A	300	RoW		Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd.	Hepatocellular Carcinoma	03/26	03/26